OMALIZUMAB
omalizumab 150 mg/mL injection, 1 mL syringe
OMALIZUMAB (11953D)
11953D
Manner of administration:Injection
Restriction 17084
Indication: Uncontrolled severe allergic asthma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $226.31 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Omlyclo | |||||